Driving Access to Medicines With a Totality of Evidence Mindset: An Opportunity for Clinical Pharmacology
Author:
Affiliation:
1. Takeda Pharmaceuticals International Co.; Cambridge Massachusetts USA
2. Pfizer Inc.; Groton Connecticut USA
Publisher
Wiley
Subject
Pharmacology (medical),Pharmacology
Reference5 articles.
1. Why has model-informed precision dosing not yet become common clinical reality? Lessons from the past and a roadmap for the future;Darwich;Clin. Pharmacol. Ther.,2017
2. From adaptive licensing to adaptive pathways: delivering a flexible life-span approach to bring new drugs to patients;Eichler;Clin. Pharmacol. Ther.,2015
3. Threshold-crossing”: a useful way to establish the counterfactual in clinical trials?;Eichler;Clin. Pharmacol. Ther.,2016
4. Toward optimum benefit-risk and reduced access lag for cancer drugs in Asia: a global development framework guided by clinical pharmacology principles;Venkatakrishnan;Clin. Transl. Sci.,2016
5. A proposal for scientific framework enabling specific population drug dosing recommendations;Jadhav;J. Clin. Pharmacol.,2015
Cited by 31 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Model‐informed Evidence for Clinical Non‐inferiority of Every‐2‐Weeks Versus Standard Weekly Dosing Schedule of Cetuximab in Metastatic Colorectal Cancer;Clinical Pharmacology & Therapeutics;2024-08-12
2. Moving the needle for oncology dose optimization: A call for action;Clinical and Translational Science;2024-06
3. Moving the needle for oncology dose optimization: A call for action;CPT: Pharmacometrics & Systems Pharmacology;2024-05-22
4. Dose Optimization in Oncology Drug Development: An International Consortium for Innovation and Quality in Pharmaceutical Development White Paper;Clinical Pharmacology & Therapeutics;2024-05-16
5. The use of ML Algo Techniques in Translational Way of HC System (Medicine);2024 4th International Conference on Advance Computing and Innovative Technologies in Engineering (ICACITE);2024-05-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3